Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial
Top Cited Papers
- 1 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 39 (1) , 87-99
- https://doi.org/10.1161/strokeaha.106.476648
Abstract
Background and Purpose— A previous randomized, placebo-controlled, double-blind study suggested that abciximab may be safe and effective in treatment of acute ischemic stroke. The current phase 3 s...Keywords
This publication has 20 references indexed in Scilit:
- Early CT Findings in Unknown-Onset and Wake-Up StrokesCerebrovascular Diseases, 2006
- Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic StrokeStroke, 2005
- Initial Safety Experience of Abciximab and Heparin for Acute Ischemic StrokeCerebrovascular Diseases, 2005
- Intravenous Administration of a GPIIb/IIIa Receptor Antagonist Extends the Therapeutic Window of Intra-Arterial Tenecteplase–Tissue Plasminogen Activator in a Rat Stroke ModelStroke, 2004
- Treatment of Acute Supratentorial Ischemic Stroke with Abciximab Is Safe and May Resultin Early Neurological ImprovementCerebrovascular Diseases, 2004
- Measuring Outcomes as a Function of Baseline Severity of Ischemic StrokeCerebrovascular Diseases, 2004
- Treatment of Acute Stroke with Recombinant Tissue Plasminogen Activator and AbciximabAcademic Emergency Medicine, 2003
- Adjuvant Treatment With a Glycoprotein IIb/IIIa Receptor Inhibitor Increases the Therapeutic Window for Low-Dose Tissue Plasminogen Activator Administration in a Rat Model of Embolic StrokeCirculation, 2003
- The Stroke Patient Who Woke UpStroke, 2002
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995